Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kleio Kappatou"'
Autor:
Srdjan Saso, Nicolas Galazis, Christos Iacovou, Kleio Kappatou, Menelaos Tzafetas, Benjamin Jones, Joseph Yazbek, Konstantinos Lathouras, Jonathan Anderson, Long R Jiao, Richard J Smith
Publikováno v:
Future Science OA, Vol 5, Iss 9 (2019)
Although a recognized condition, growing teratoma syndrome (GTS) has no guidelines for management, and patients diagnosed with the condition are managed empirically by the most appropriate teams. We report a case of GTS in a 33-year-old patient who w
Externí odkaz:
https://doaj.org/article/1576437047a54ff5b3c7cd3aa584488b
Autor:
Kleio Kappatou, Dimitrios Rallis, Konstantina Karantanou, Foteini Balomenou, Meropi Tzoufi, Vasileios Giapros
Publikováno v:
The journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 35(25)
C-reactive protein (CRP) is one of the most extensively used biomarkers in the investigation of early-onset sepsis (EOS). Current evidence suggests the normal kinetics of serum CRP should be considered when evaluating infants for presumable EOS. The
Autor:
Benjamin P Jones, Srdjan Saso, Konstantinos Lathouras, Nicolas Galazis, Richard J Smith, Menelaos Tzafetas, Christos Iacovou, Jonathan R Anderson, Long R. Jiao, Kleio Kappatou, Joseph Yazbek
Publikováno v:
Future Science OA
Although a recognized condition, growing teratoma syndrome (GTS) has no guidelines for management, and patients diagnosed with the condition are managed empirically by the most appropriate teams. We report a case of GTS in a 33-year-old patient who w
Autor:
Konstantina Karantanou, Dimitrios Rallis, Foteini Balomenou, Meropi Tzoufi, Kleio Kappatou, Vasileios Giapros
Publikováno v:
Early Human Development. 155:105331
Background The management of neonates with early-onset sepsis (EOS) is based on maternal risk factors and infant clinical indications. An online sepsis risk calculator (SRC) has been established taking into consideration how clinical appearance modif